Stanelco PLC
16 March 2004
STANELCO, INGEL TECHNOLOGIES: RADIO FREQUENCY ENCAPSULATION
Stanelco plc, the RF (radio frequency) applications group is pleased to report
significant progress with its InGel Technologies Limited venture.
Stanelco has successfully demonstrated the use of RF technology to rapidly
manufacture soft, one-piece capsules for oral and topical (applied to skin)
applications using water-soluble materials. With the success of this
demonstration, the company will now design and build a pilot commercial scale
machine for manufacturing capsules to nutritional- and pharmaceutical-standards,
Commenting, Ian Balchin, Chief Executive of Stanelco, said: 'This is a true
breakthrough in the commercial processing of water-soluble and edible materials
which I believe is leading to a revolutionary new generation of commercial RF
processing equipment. It is a major milestone for all parties involved and the
achievement is a reflection upon the calibre and know-how of the team of people
we have working for InGel - they are to be congratulated. Work is now focusing
on further optimising all aspects of the processing economics prior to the
anticipated commercial launch.'
InGel Technologies is a co-venture between Stanelco, plc. and Cardinal Health,
the leading provider of products and services for the health care industry.
Notes to Editors:
Stanelco was founded in 1953 and is a world leader in the design and manufacture
of optical fibre furnace technology, induction heating and dielectric welding
equipment. The company's current core business is the manufacture of optical
fibre using RF technology. Stanelco has been applying its technology to other
markets and is currently developing detergent capsules, foamed starch trays,
edible sachets and waste packing.
• ENDS -
For further information, please contact:
Ian Balchin, Chief Executive
Stanelco plc - Tel: 01489 570991
Caroline Sturdy
Bell Pottinger Financial - Tel: 020 7861 3232
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.